Wave Life Sciences Stock Performance
WVE Stock | USD 5.08 0.24 4.96% |
On a scale of 0 to 100, Wave Life holds a performance score of 5. The firm maintains a market beta of 2.98, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Wave Life will likely underperform. Please check Wave Life's semi variance, as well as the relationship between the daily balance of power and period momentum indicator , to make a quick decision on whether Wave Life's historical returns will revert.
Risk-Adjusted Performance
5 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Wave Life Sciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Wave Life exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 6.2 | Five Day Return 7.76 | Year To Date Return (3.75) | Ten Year Return (67.87) | All Time Return (67.87) |
1 | Acquisition by Chandra Vargeese of 361700 shares of Wave Life subject to Rule 16b-3 | 02/07/2024 |
2 | Acquisition by Adrian Rawcliffe of 45000 shares of Wave Life at 4.58 subject to Rule 16b-3 | 03/22/2024 |
3 | Inhalation Capsules Market to Reach 1.5 Billion Globally by 2032 at 6.4 percent CAGR Allied Market Research | 03/27/2024 |
4 | Kalray Announces the Availability of Its TURBOCARD4 Card a Paradigm Shift in Compute Acceleration for Smart Vision and Gen-AI Data-indexing Applications | 04/02/2024 |
5 | Navigate BioPharma Services, Inc. announces collaboration with RareCyte, Inc. to provide enhanced spatial biology capabilities using the Orion Platform | 04/09/2024 |
6 | Expert.ai Launches Insight Engine for Life Sciences | 04/15/2024 |
7 | Emphysema Treatment Market to Reach 8.7 Billion, Globally, by 2032 at 3.3 percent CAGR Allied Market Research | 04/16/2024 |
8 | TOWER CAPITAL GROUP Reveals Esteemed Multidisciplinary Generational Health Advisors | 04/17/2024 |
9 | Intramedullary Nails Market to Reach 1.7 Billion Globally by 2032 at 5.6 percent CAGR Allied Market Research | 04/18/2024 |
10 | Infosys Q4 Earnings and Revenues Surpass Estimates | 04/19/2024 |
Begin Period Cash Flow | 88.5 M |
Wave |
Wave Life Relative Risk vs. Return Landscape
If you would invest 439.00 in Wave Life Sciences on January 25, 2024 and sell it today you would earn a total of 69.00 from holding Wave Life Sciences or generate 15.72% return on investment over 90 days. Wave Life Sciences is generating 0.4025% of daily returns assuming volatility of 6.0197% on return distribution over 90 days investment horizon. In other words, 53% of stocks are less volatile than Wave, and above 93% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
Risk |
Wave Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Wave Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Wave Life Sciences, and traders can use it to determine the average amount a Wave Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0669
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | WVE | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
6.02 actual daily | 53 53% of assets are less volatile |
Expected Return
0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Wave Life is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Wave Life by adding it to a well-diversified portfolio.
Wave Life Fundamentals Growth
Wave Stock prices reflect investors' perceptions of the future prospects and financial health of Wave Life, and Wave Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Wave Stock performance.
Return On Equity | -11.18 | ||||
Return On Asset | -0.2 | ||||
Profit Margin | (0.51) % | ||||
Operating Margin | (0.64) % | ||||
Current Valuation | 431.5 M | ||||
Shares Outstanding | 122.28 M | ||||
Price To Earning | (6.50) X | ||||
Price To Book | 17.90 X | ||||
Price To Sales | 6.26 X | ||||
Revenue | 113.31 M | ||||
Gross Profit | (73.64 M) | ||||
EBITDA | (58.79 M) | ||||
Net Income | (57.51 M) | ||||
Cash And Equivalents | 148.16 M | ||||
Cash Per Share | 1.71 X | ||||
Total Debt | 32.12 M | ||||
Debt To Equity | 1.02 % | ||||
Current Ratio | 2.50 X | ||||
Book Value Per Share | 0.33 X | ||||
Cash Flow From Operations | (19.43 M) | ||||
Earnings Per Share | (0.54) X | ||||
Market Capitalization | 591.85 M | ||||
Total Asset | 274.95 M | ||||
Retained Earnings | (1.02 B) | ||||
Working Capital | 48.93 M | ||||
Current Asset | 161.38 M | ||||
Current Liabilities | 3.82 M | ||||
About Wave Life Performance
To evaluate Wave Life Sciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Wave Life generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Wave Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Wave Life Sciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Wave's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 0.000046 | 0.000043 | |
Return On Tangible Assets | (0.21) | (0.22) | |
Return On Capital Employed | (0.77) | (0.81) | |
Return On Assets | (0.21) | (0.22) | |
Return On Equity | (1.21) | (1.27) |
Things to note about Wave Life Sciences performance evaluation
Checking the ongoing alerts about Wave Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Wave Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Wave Life Sciences had very high historical volatility over the last 90 days | |
The company reported the last year's revenue of 113.31 M. Reported Net Loss for the year was (57.51 M) with loss before taxes, overhead, and interest of (73.64 M). | |
Wave Life Sciences has about 148.16 M in cash with (19.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.71. | |
Wave Life Sciences has a poor financial position based on the latest SEC disclosures | |
Roughly 75.0% of the company outstanding shares are owned by institutional investors | |
Latest headline from finance.yahoo.com: Infosys Q4 Earnings and Revenues Surpass Estimates |
- Analyzing Wave Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Wave Life's stock is overvalued or undervalued compared to its peers.
- Examining Wave Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Wave Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Wave Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Wave Life's stock. These opinions can provide insight into Wave Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Wave Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Wave Stock analysis
When running Wave Life's price analysis, check to measure Wave Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wave Life is operating at the current time. Most of Wave Life's value examination focuses on studying past and present price action to predict the probability of Wave Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wave Life's price. Additionally, you may evaluate how the addition of Wave Life to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Wave Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Wave Life. If investors know Wave will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Wave Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Revenue Per Share 1.068 | Quarterly Revenue Growth 22.451 | Return On Assets (0.20) | Return On Equity (11.18) |
The market value of Wave Life Sciences is measured differently than its book value, which is the value of Wave that is recorded on the company's balance sheet. Investors also form their own opinion of Wave Life's value that differs from its market value or its book value, called intrinsic value, which is Wave Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Wave Life's market value can be influenced by many factors that don't directly affect Wave Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Wave Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.